CENPF

Chr 1AR

centromere protein F

Also known as: CENF, CILD31, PRO1779, STROMS, hcp-1

This gene encodes a protein that associates with the centromere-kinetochore complex. The protein is a component of the nuclear matrix during the G2 phase of interphase. In late G2 the protein associates with the kinetochore and maintains this association through early anaphase. It localizes to the spindle midzone and the intracellular bridge in late anaphase and telophase, respectively, and is thought to be subsequently degraded. The localization of this protein suggests that it may play a role in chromosome segregation during mitotis. It is thought to form either a homodimer or heterodimer. Autoantibodies against this protein have been found in patients with cancer or graft versus host disease. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.731 OMIM phenotype
Clinical SummaryCENPF
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
65 unique Pathogenic / Likely Pathogenic· 530 VUS of 953 total submissions
📖
GeneReview available — CENPF
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.73LOEUF
pLI 0.000
Z-score 4.14
OE 0.61 (0.510.73)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.03Z-score
OE missense 1.00 (0.961.05)
1473 obs / 1469.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.61 (0.510.73)
00.351.4
Missense OE?1.00 (0.961.05)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 79 / 129.9Missense obs/exp: 1473 / 1469.8Syn Z: -0.30
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCENPF-related Stromme syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.74top 25%
GOF
0.6248th %ile
LOF
0.2774th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

953 submitted variants in ClinVar

Classification Summary

Pathogenic27
Likely Pathogenic38
VUS530
Likely Benign203
Benign96
Conflicting30
27
Pathogenic
38
Likely Pathogenic
530
VUS
203
Likely Benign
96
Benign
30
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
27
0
0
0
27
Likely Pathogenic
38
0
0
0
38
VUS
6
515
6
3
530
Likely Benign
0
39
53
111
203
Benign
0
31
51
14
96
Conflicting
30
Total71585110128924

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

16 pathogenic / likely-pathogenic (of 22) ClinVar copy-number / structural variants overlap CENPF — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CENPF · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →